semaglutide compound update Compounded Safety: What You Should Know The End of Compounded Semaglutide:

The FDA does not ban legal compoundingit regulates the facilities and processes that prepare these medications

The proportion of patients with PCOS who were prescribed semaglutide or tirzepatide increased from 2.4% in 2021 to 17.6% in 2025, representing a 637.5% relative increase

Fast approval and discreet shipping are common praise points in reviews

Articles focusing exclusively on non-dermatologic or non-cutaneous outcomes without translational relevance were excluded

Weve spent the last two years drawing on Nooms deep expertise in behavior change to create the ultimate GLP-1 companion program to solve the medications twin challenges, persistence and muscle-mass loss, while also driving enhanced weight loss outcomes

Clinical network: OpenLoop Health provides the prescribing clinical layer